676515-34-7 Usage
Description
6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one is a naphthyridine derivative with the molecular formula C11H8BrNO. It is a heterocyclic compound that contains a bromine atom and is commonly used as an intermediate in the pharmaceutical industry for the synthesis of various pharmaceuticals. 6-BroMo-2,3-dihydro-1,8-naphthyridin-4(1H)-one exhibits a range of biological activities and is being studied for its potential therapeutic applications, making it a promising candidate for drug development and medicinal chemistry research.
Uses
Used in Pharmaceutical Industry:
6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and biological activities make it a valuable component in the development of new drugs.
Used in Drug Development:
As a heterocyclic compound with a bromine atom, 6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one holds potential for drug development. Its diverse biological activities and compatibility with various chemical modifications make it a promising candidate for the creation of novel therapeutic agents.
Used in Medicinal Chemistry Research:
6-Bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one is utilized in medicinal chemistry research to explore its potential therapeutic applications. Its unique structure and properties allow researchers to investigate its interactions with biological targets and evaluate its efficacy in treating various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 676515-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,1 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 676515-34:
(8*6)+(7*7)+(6*6)+(5*5)+(4*1)+(3*5)+(2*3)+(1*4)=187
187 % 10 = 7
So 676515-34-7 is a valid CAS Registry Number.
676515-34-7Relevant articles and documents
Substituted ring compound and its method and use thereof
-
, (2017/08/25)
The invention provides a substituted cyclic compound as well as a use method and application thereof. The compound is a compound as shown in a formula (I) or stereoisomers, stereomers, tautomers, nitric oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as shown in the formula (I). The invention further provides a medicament composition containing the compound. The compound and the medicament composition are capable of regulating the activity of protein kinase in a biological sample body and are used for protecting, treating or relieving proliferative diseases of patients. The formula (I) is as shown in the specification.
SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF USE
-
, (2014/06/24)
The present invention provides novel substituted alkynyl compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
METABOTROPIC GLUTAMATE RECEPTOR MODULATORS
-
Page/Page column 51, (2012/05/05)
The invention relates to heterocyclic derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders wherein Y, W, R1, R2 and R3 are as defined in claim 1.
